Low serum free and total tri-iodothyronine hormones as possible prognostic factors in liver cirrhotic patients because of chronic hepatitis C

2015 ◽  
Vol 43 (2) ◽  
pp. 46 ◽  
Author(s):  
MohamedA Tawfik ◽  
Abd-AllahA El-Sawy
Keyword(s):  
Chronic Hepatitis ◽  
Prognostic Factors ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Serum Free ◽  
Cirrhotic Patients ◽  
Low Serum

scholarly journals Ineffective Absorption? Failure of Direct-Acting Therapy for Chronic Hepatitis C in Cirrhotic Patients With Roux-en-Y Gastric Bypass

2019 ◽  
Vol 7 ◽  
pp. 232470961985812
Author(s):  
Clara Y. Tow ◽  
John F. Reinus
Keyword(s):  
Gastric Bypass ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Virologic Response ◽  
Response To Therapy ◽  
Direct Acting Antiviral ◽  
Cirrhotic Patients ◽  
Direct Acting ◽  
Short Courses

In this era of direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection, treated patients have extremely high rates of sustained virologic response to short courses of therapy regardless of stage of fibrosis. Treatment failure is uncommon and often attributed to medication noncompliance or viral resistance to drug. This report describes 2 Child-Pugh-A cirrhotic patients who failed to clear HCV in response to therapy with DAAs. Each patient had Roux-en-Y gastric bypass (RYGB) surgery preceding DAA therapy. RYGB may create multiple barriers to adequate DAA absorption as a result of changes in gastrointestinal physiology. Treatment monitoring and duration should be carefully considered in this unique patient population.

611 Poor prognostic factors in heavier patients with chronic hepatitis C (CHC) result in less favourable treatment outcomes

2006 ◽  
Vol 44 ◽  
pp. S227 ◽  
Author(s):  
M.G. Swain ◽  
G.R. Foster ◽  
S.J. Hadzivannis ◽  
E.J. Heathcote ◽  
D. Jensen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Prognostic Factors ◽  
Hepatitis C ◽  
Treatment Outcomes ◽  
Chronic Hepatitis C
Sign in / Sign up

Export Citation Format

Share Document